Market Cap 404.53M
Revenue (ttm) 41.24M
Net Income (ttm) -400.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -971.56%
Debt to Equity Ratio 0.00
Volume 699,800
Avg Vol 1,046,142
Day's Range N/A - N/A
Shares Out 62.62M
Stochastic %K 30%
Beta 0.20
Analysts Sell
Price Target $8.18

Latest News on SAGE

Sage Therapeutics, Inc. (SAGE) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 10:33 PM EDT - 5 weeks ago

Sage Therapeutics, Inc. (SAGE) Q1 2025 Earnings Call Transcript


Sage Therapeutics Announces R&D Leadership Transition

Mar 4, 2025, 4:15 PM EST - 3 months ago

Sage Therapeutics Announces R&D Leadership Transition


Sage Therapeutics, Inc. (SAGE) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 9:29 PM EST - 4 months ago

Sage Therapeutics, Inc. (SAGE) Q4 2024 Earnings Call Transcript


Sage Therapeutics, Inc. (SAGE) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 9:35 PM EDT - 7 months ago

Sage Therapeutics, Inc. (SAGE) Q3 2024 Earnings Call Transcript